26
Oversold
Moving averages
SMA 200$19.99-93.05%
Company profile
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
SectorHealthcare
IndustryBiotechnology
Market cap$1.15M
P/E ratioNone
EPS$-130.07
Beta-0.006
Dividend yield0.00%
52-week high$95.04
52-week low$1.91
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ZVSA
ZyVersa Therapeutics Inc
RSI 16
VRAX
Virax Biolabs Group Ltd - Class A
RSI 19
IMNN
Imunon Inc
RSI 25
ACXP
Acurx Pharmaceuticals Inc
RSI 45
SKYE
Skye Bioscience Inc
RSI 32
SNGX
Soligenix Inc
RSI 21
RSI alerts for ARTL
An email when ARTL closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:13 AM EST